Top
Main
 
All Outcomes
 
Feedback
Home
c19early.org COVID-19 treatment researchAlkalinizationAlkalinization (more..)
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta
Cannabidiol Meta Molnupiravir Meta
Colchicine Meta
Conv. Plasma Meta
Curcumin Meta Nigella Sativa Meta
Ensovibep Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Peg.. Lambda Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Ivermectin Meta
Lactoferrin Meta

Loading...

Supplementary Data — Alkalinization for COVID-19: real-time meta analysis of 8 studies

@CovidAnalysis, September 2023
https://c19early.org/phmeta.html
 
0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Baxter (RCT) 65% 0.35 [0.01-8.27] hosp. 0/37 1/42 OT​1 Improvement, RR [CI] Treatment Control Mody (RCT) 64% 0.36 [0.19-0.68] no improv. 8/30 22/30 Soares (ICU) 76% 0.24 [0.11-0.54] death 6/44 18/32 ICU patients Delić (RCT) 20% 0.80 [0.54-1.18] death 20/42 31/52 Intubated patients El-Badrawy 57% 0.43 [0.09-2.08] death 3/127 3/55 El-Badrawy 39% 0.61 [0.20-1.83] progression 7/127 5/55 El-Badrawy 19% 0.81 [0.68-0.96] no recov. 84/127 45/55 El-Badrawy 73% 0.27 [0.14-0.52] no recov. 127 (n) 55 (n) El-Badrawy 66% 0.34 [0.25-0.47] recov. time 127 (n) 55 (n) El-Badrawy (RCT) 23% 0.77 [0.50-1.18] death 32/272 42/274 El-Badrawy (RCT) 55% 0.45 [0.23-0.87] death 12/247 27/251 El-Badrawy (RCT) 79% 0.21 [0.02-1.76] death 1/125 5/130 El-Badrawy (RCT) 53% 0.47 [0.25-0.88] death 11/63 22/59 El-Badrawy (RCT) -23% 1.23 [0.86-1.75] death 20/25 15/23 El-Badrawy (RCT) 28% 0.72 [0.66-0.80] recov. time 272 (n) 274 (n) El-Badrawy (RCT) 33% 0.67 [0.52-0.85] no recov. 238 (n) 229 (n) Wang (RCT) 39% 0.61 [0.46-0.82] hosp. time 23 (n) 32 (n) Pantazop.. (SB RCT) 67% 0.33 [0.01-7.85] death 0/28 1/28 Pantazop.. (SB RCT) 67% 0.33 [0.01-7.85] ICU 0/28 1/28 Pantazop.. (SB RCT) 80% 0.20 [0.01-3.99] oxygen 0/28 2/28 Pantazop.. (SB RCT) 42% 0.58 [0.34-0.98] viral+ 11/28 19/28 Alkalinization COVID-19 outcomes c19early.org Sep 2023 1 OT: comparison with other treatment Favors alkalinization Favors control
Figure S1. All outcomes.
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit